Rhumbline Advisers Acquires 10,608 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI)
Rhumbline Advisers grew its holdings in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) by 13.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,482 shares of the company’s stock after buying an additional 10,608 shares during the quarter. Rhumbline […]
Rhumbline Advisers grew its holdings in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) by 13.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,482 shares of the company’s stock after buying an additional 10,608 shares during the quarter. Rhumbline […]
